Seoul Viosys Ahead of March Listing, "Targeting New Markets with Micro Clean Pixel, Big Cell, and Biorez Technologies"

[Asia Economy Reporter Oh Ju-yeon] "We will create and expand various markets with second-generation LED patent technologies such as existing visible light devices, UV Bioleds (Violeds), big cell (VCSEL), and Micro Clean Pixel."

Lee Jong-deok, CEO of Seoul Viosys, said this at a press conference held on the 17th in Yeouido, Seoul.

Seoul Viosys is a subsidiary of Seoul Semiconductor specializing in LED chip research, development, and manufacturing. It was established in 2002 through a cooperation agreement with the Japanese venture company Nightride Semiconductors. It holds the world's number one market share in the UV LED sector and possesses a product portfolio and related technology patents covering all wavelength ranges (200nm~1600nm) from ultraviolet (UV) to visible ray and infrared (IR), with over 4,000 patents. Combined with its parent company Seoul Semiconductor, it holds about 14,000 patents in total. Seoul Viosys is uniquely competitive as the only company worldwide capable of developing and mass-producing LED and laser diode devices across all wavelength ranges.

The representative proprietary technology, UV LED Bioleds, provides solutions across a wide range of industries using only light without harmful chemicals, including sterilization and disinfection (UVC), skin regeneration (UVB), air and water purification, insect control, and plant growth promotion.

A company official emphasized, "Seoul Viosys's Bioleds technology is an eco-friendly UV LED technology harmless to humans, capable of sterilizing 90% of coronavirus in the air," adding, "It can sterilize over 97% of various bacteria such as influenza virus, E. coli, and Staphylococcus aureus, and these performances have been verified by professional testing institutions." The company expects that Seoul Viosys's Bioleds technology will be increasingly applied to demand sectors requiring clean technology for water, air, and surface sterilization in the future.

The big cell laser diode technology is expected to show high growth due to increasing demand in sensor and communication fields. It is an essential device for 3D facial recognition and proximity sensors and is widely anticipated to be used in enabling ultra-high-definition video transmission and ultra-high-speed data communication in the 5G era.

In 2018, Seoul Viosys acquired Raycan, a big cell specialized company, securing next-generation big cell technology supporting smartphone facial recognition and autonomous driving for automobiles, and began full-scale product mass production.

In January 2020, the company launched the differentiated single-pixel RGB 'Micro Clean Pixel' to replace the existing display market and started market penetration.

Seoul Viosys's new technology, Micro Clean Pixel, was introduced and well received at CES 2020 held last month in Las Vegas, USA. Together with its parent company Seoul Semiconductor, Seoul Viosys established the world's first full-process mass production system from micro LED chip manufacturing to transfer and module. It began mass production in the second half of last year, and its performance in this field is expected to increase significantly starting this year.

A company official stated, "Seoul Viosys is enhancing its technological competitiveness through continuous R&D and building a strong patent portfolio, leading second-generation LED technology," adding, "We will further expand our dominance in existing markets while strengthening cost competitiveness to rapidly commercialize new technologies and achieve a quantum jump."

Seoul Viosys will newly issue a total of 2 million shares through this public offering. The desired public offering price range per share is between 6,500 KRW and 7,500 KRW. From the 20th, after demand forecasting for institutions, shares will be preferentially allocated to institutions that offer higher prices or submit binding commitments based on the finalized public offering price.

General investor subscription will be on the 26th and 27th. The company plans to use the public offering funds mainly for major facility investments and research and development. KB Securities is overseeing the overall listing process, and Seoul Viosys is scheduled to be listed on the KOSDAQ market on the 6th of next month.